A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

Author： Schubert Mark  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.15, Iss.10, 2007-10, pp. : 1145-1154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

By Hu Zhihuang   Cheng Ying   Zhang Hongyu   Zhou Caicun   Han Baohui   Zhang Yiping   Huang Cheng   Chang Jianhua   Song Xiangqun   Liang Jun   Liang Houjie   Bai Chunxue   Yu Shiying   Chen Jia   Wang Jie   Pan Hongming   Chitkara Denesh   Hille Darcy   Zhang Li  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

By Awidi A.   Homsi U.   Kakail R.I.   Mubarak A.   Hassan A.   Kelta M.   Martinez P.   Sulaiti S.   Al Qady A.   Jamhoury A.   Daniel M.   Charles C.   Ambrose A.   El-Aloosy A.S.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2010-2014

Elsevier

Access to resources Recommend Favorite

L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 33-39

Spandidos Publications

Access to resources Recommend Favorite

Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

By Hovey Elizabeth   de Souza Paul   Marx Gavin   Parente Phillip   Rapke Tal   Hill Andrew   Bonaventura Antonino   Michele Antony   Craft Paul   Abdi Ehtesham   Lloyd Andrew  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1233-1242

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

By Miles David   Baselga José   Amadori Dino   Sunpaweravong Patrapim   Semiglazov Vladimir   Knott Adam   Clark Emma   Ross Graham   Swain Sandra  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 89-99

Springer Publishing Company

Access to resources Recommend Favorite